K Number
K171035
Manufacturer
Date Cleared
2017-09-06

(153 days)

Product Code
Regulation Number
890.5850
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Katalyst Mark 1 is intended to stimulate healthy muscles in order to improve or facilitate muscle performance.

It is not intended to be used in conjunction with therapy or treatment of medical conditions of any kind. None of the training programs or operational parameters are designed to target injured or ailing muscles and its use on such muscles is contraindicated.

The Katalyst Mark 1 is Rx only.

Device Description

The Katalyst Mark 1 Muscle Stimulation System consists of the following three main components:
Katalyst Suit: Worn by the client, the Katalyst Suit is a compression textile with embedded electrodes connected by a cable harness. When connected to the Impulse Pack it provides localized EMS impulses to major muscle groups at controllable intensities.
Impulse Pack: A powered muscle stimulation device specifically designed to mate with the Katalyst Suit through a single port connector. It delivers electrical impulses through a battery powered regulated booster. The Impulse Pack is operator controlled wirelessly via the Katalyst Application over Bluetooth.
Katalyst Application: Controlled by the Operator, the Katalyst Application is run on a Microsoft Surface Pro 3 running Windows 10 Professional. It is used to configure and run a Katalyst training, including the setting of independent intensities for each muscle group channel.
Accessories included: cable harnesses and an Impulse Pack charging cable.

AI/ML Overview

The provided document is a 510(k) Summary for the Katalyst Mark 1 Muscle Stimulation System. It details the device, its indications for use, comparison with predicate devices, and non-clinical testing performed to demonstrate substantial equivalence. However, it does not contain a study that establishes acceptance criteria and then proves the device meets those criteria in the context of device performance metrics like sensitivity, specificity, accuracy, or effect size for AI assistance.

Instead, the document outlines various non-clinical tests conducted to demonstrate that the device is substantially equivalent to existing predicate devices in terms of safety and effectiveness, based on recognized standards and guidance. The 'acceptance criteria' in this context refer to compliance with these standards and established performance parameters of the predicate devices, rather than a specific performance target for diagnostic or assistive accuracy.

Therefore, many of the requested sections of your prompt, particularly those related to a clinical study demonstrating AI performance, sample sizes for test/training sets, expert ground truth, adjudication methods, and MRMC studies, cannot be extracted from this document as such information is not present. The Katalyst Mark 1 is a physical muscle stimulation system, not an AI-powered diagnostic or assistive tool in the way your prompt defines.

Here's what can be extracted based on the provided text:

1. A table of acceptance criteria and the reported device performance

Since this is a 510(k) for a powered muscle stimulator, the "acceptance criteria" are primarily based on compliance with electrical safety, EMC, and biocompatibility standards, as well as a comparison of its technical specifications (e.g., waveform, output voltage, current, pulse width, frequency) to predicate devices to establish substantial equivalence.

Acceptance Criteria (Compliance/Comparison)Reported Device Performance (Katalyst Mark 1)
Biocompatibility (ISO 10993-10:2009, ISO 10993-5:2009)Tested to standards under GLP.
Software Verification & Validation (Moderate level of concern)All software requirement specifications met, all software hazards mitigated to Accepted risk level.
Electrical Safety (IEC/EN 60601-1:2005 Ed 3.1)Complies and tested.
Muscle Stimulator Specific Safety (IEC 60601-2-10:2012 Ed 2.0)Complies and tested. Specifically, concerning current density >2mA/cm², additional warnings and guidance included in Operator's Guide, and tested to standard.
Electromagnetic Compatibility (EMC) (IEC/EN 60601-1-2:2014 Ed 4.0)Complies and tested.
Battery Safety (IEC 62133 Ed 2.0, for Li-Po)Tested by battery manufacturer for compliance.
Wireless Risks Mitigation (FDA Guidance: "Radio Frequency Wireless Technology in Medical Devices")System validation testing scenarios covering mitigation of wireless risks were added to full system testing protocol to ensure safe and effective use.
Output WaveformSymmetrical Biphasic, Rectangular.
Maximum Output Voltage60 V @ 500 Ω, 96 V @ 2 kΩ, 114.2 V @ 10 kΩ.
Maximum Output Current120 mA @ 500 Ω, 48 mA @ 2 kΩ, 11 mA @ 10 kΩ.
Positive Pulse Width75µs or 175µs.
Negative Pulse Width75µs or 175µs.
Frequency85Hz or 100Hz.
Net Charge [µC/pulse]0.5 [µC] @ 500Ω, Excitation pulse fully compensated.
Maximum Phase Charge [µC]21µC @ 500 Ω.
Maximum Current (RMS) Density [mA/cm2]2.4mA/cm² @ 500Ω.
Maximum Power Density [mW/cm2]5.04mW/cm² @ 500 Ω.
Adherence to FDA Guidance Document for Powered Muscle Stimulator 510(k)s (1999)Testing conducted in accordance with recommendations.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

This information is not applicable and not provided. The testing described is non-clinical (bench testing, software validation, component testing) rather than a study on a "test set" of patient data.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not applicable and not provided as this is not a diagnostic device involving expert ground truth for image interpretation or similar.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This information is not applicable and not provided.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This information is not applicable and not provided. The device is a muscle stimulator, not an AI-assisted diagnostic tool for human readers.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

This information is not applicable and not provided. The "system validation testing" for software ensures that the device's software functions as intended to control the electrical stimulation, but it's not an AI algorithm performing a diagnostic or interpretive task.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

For the non-clinical tests described:

  • Biocompatibility: Ground truth is established by the pass/fail criteria of the ISO 10993 standards.
  • Software Verification and Validation: Ground truth is established by the software requirement specifications and hazard analysis.
  • Electrical Safety, EMC, Battery Testing: Ground truth is established by the pass/fail criteria of the respective IEC/EN standards.
  • Engineering Bench Testing: Ground truth is established by comparing measured output waveforms, voltages, currents, etc., against the specified design parameters and potentially against predicate device performance characteristics (though not explicitly stated as direct comparison on every parameter, rather overall substantial equivalence).

8. The sample size for the training set

This information is not applicable and not provided. The term "training set" is usually relevant for machine learning models, which is not the primary focus of this submission. The software validation is for deterministic software.

9. How the ground truth for the training set was established

This information is not applicable and not provided.

{0}------------------------------------------------

Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines representing hair or a stream.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 6, 2017

Katalyst Inc. Amish Patel Chief Product Officer 316 Occidental Avenue South B300 Seattle, Washington 98104

Re: K171035

Trade/Device Name: Katalyst Mark 1 Muscle Stimulation System Regulation Number: 21 CFR 890.5850 Regulation Name: Powered Muscle Stimulator Regulatory Class: Class II Product Code: NGX Dated: August 1, 2017 Received: August 3, 2017

Dear Mr. Patel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Vivek J. Pinto -S

for Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K171035

Device Name

Katalyst Mark 1 Muscle Stimulation System

Indications for Use (Describe)

The Katalyst Mark 1 is intended to stimulate healthy muscles in order to improve or facilitate muscle performance.

It is not intended to be used in conjunction with therapy or treatment of medical conditions of any kind. None of the training programs or operational parameters are designed to target injured or ailing muscles and its use on such muscles is contraindicated.

The Katalyst Mark 1 is Rx only.

Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D) □ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(K) SUMMARY

This summary is being submitted in accordance with the requirements of 21 CFR 807.92.

1.1 Submitter

Katalyst Inc. 316 Occidental Avenue S. B300 Seattle, WA 98104

Contact: Amish Patel, Chief Product Officer Tel: 406-616-3671 Email: devices@katalyst-fitness.com

1.2 Date Prepared

September 6, 2017

1.3 Device Name and Classification Information:

Trade/Proprietary Name: Katalyst Mark 1 Muscle Stimulation System Common Name: Powered Muscle Stimulator for Muscle Conditioning Classification Name: Powered Muscle Stimulator Classification: 21 CFR 890.5850, Class II Product Code: NGX Panel: 89, Physical Medicine

1.4 Predicate Devices

Primary Predicate: Compex® Sport Plus (K083140)

Secondary Predicate: E-Fit EF-1280 (K133225)

1.5 Device Description

The Katalyst Mark 1 Muscle Stimulation System consists of the following three main components:

Katalyst SuitWorn by the client, the Katalyst Suit is a compression textilewith embedded electrodes connected by a cable harness. Whenconnected to the Impulse Pack it provides localized EMSimpulses to major muscle groups at controllable intensities.
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

{4}------------------------------------------------

Impulse PackA powered muscle stimulation device specifically designed tomate with the Katalyst Suit through a single port connector. Itdelivers electrical impulses through a battery powered regulatedbooster. The Impulse Pack is operator controlled wirelessly viathe Katalyst Application over Bluetooth.
KatalystApplicationControlled by the Operator, the Katalyst Application is run on aMicrosoft Surface Pro 3 running Windows 10 Professional. It isused to configure and run a Katalyst training, including thesetting of independent intensities for each muscle group channel.

Accessories included: cable harnesses and an Impulse Pack charging cable.

1.6 Indications for Use:

The Katalyst Mark 1 is intended to stimulate healthy muscles in order to improve or facilitate muscle performance.

It is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. None of the training programs or operational parameters are designed to target injured or ailing muscles and its use on such muscles is contraindicated.

The Katalyst Mark 1 is Rx only.

1.7 Contraindications

The Katalyst Mark 1 should only be operated by a certified Katalyst Operator. Trainings should not be used by anyone under 18 years of age, with a cardiac pacemaker, with known heart conditions, with a history of cardiac arrhythmia, who is pregnant, with an implanted defibrillator, or with other implanted metallic or electronic device. Such use could cause cardiac arrhythmia, electric shock, burns, electrical interference, or death. Other contraindications are provided in the operator guide.

1.8 Basic Device Characteristics - Comparison with Predicate Devices

CharacteristicNew Device(Katalyst Mark 1Muscle StimulationSystem)Primary PredicateCompex Sport Plus(K083140)SecondaryPredicate:E-Fit EF-1280(K133225)Similar/Different
Device Name,ModelKatalyst Mark 1 MuscleStimulation SystemCompex Sport Plus(currently marketed)E-Fit EF-1280K083140 -Different
Manufactureras Compex Sport Elite)K133225 - DifferentK083140 - Different
Katalyst Inc.DJO LLCFIT PRO, LLCK133225 - DifferentK083140 - SimilarK133225 - Similar
Indications for UseThe Katalyst Mark 1 is intended to stimulate healthy muscles in order to improve or facilitate muscle performance.It is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. None of the training programs or operational parameters are designed to target injured or ailing muscles and its use on such muscles is contraindicated.The Katalyst Mark 1 is Rx only.The Compex® Sport Plus is intended to stimulate healthy muscles in order to improve or facilitate muscle performance.The Compex® Sport Plus is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. None of the Compex® Sport Plus training programs is designed for injured or ailing muscles and its use on such muscles is contraindicated.The Compex® Sport Plus electrical impulses allow the triggering of action potentials on motoneurones of motor nerves (excitations). These excitations of motoneurones are transmitted to the muscle fibers via theE-fit EF-1280 is a machine with electronic muscle stimulation based on EMS technology. Regarding its use, the device is specifically designed as an addition to other sports and for training muscles. It must be used for only healthy muscles and clients, not for rehabilitation purposes.The E-Fit EF-1280 intended to stimulate healthy muscles in order to improve or facilitate muscle performance.The E-Fit EF-1280 is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. None

{5}------------------------------------------------

{6}------------------------------------------------

motor endplatewhere they generatemechanical musclefiber responses thatcorrespond tomuscle work.Depending on theparameters of theelectrical impulses(pulse frequency,duration ofcontraction,duration of rest,total sessionduration), differenttypes of musclework can beimposed on thestimulated muscles.The various types ofmuscle work thatthe Compex® SportPlus can impose onthe stimulatedmuscles are able toimprove or facilitatemuscleperformance.The Compex®Sport Plus maytherefore beconsidered atechnique of muscletrainingof the E-Fit EF-1280 trainingprograms isdesigned forinjured or ailingmuscles and itsuse on suchmuscles iscontraindicated.The E-Fit EF-1280 electricalimpulses allowthe triggering ofaction potentialsonmotoneurones ofmotor nerves(excitations).Theseexcitations ofmotoneuronesare transmittedto the musclefibers via themotor endplatewhere theygeneratemechanicalmuscle fiberresponses thatcorrespond tomuscle work.Depending onthe parametersof the electricalimpulses (pulsefrequency,duration ofcontraction,duration of rest,total sessionduration),different typesof muscle work
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

{7}------------------------------------------------

Connection ofdevice toelectrodesThe Katalyst ImpulsePack unit is connected tothe electrodes via a cableelectrode harness. Theconnection to theImpulse Pack is via aROHS compliantstandard DB-25 Femaleconnector, and snappingonto the electrodes usingstandard 4mm SNAPconnectors integrated inthe electrodesthemselves. The SNAPheaders are combinedand over molded in thelead cables.With 6-pole cablesincluding femalecustom SNAPplugged on thecustom Compexfemale SNAPassembled in theelectrode. Entireelectronic circuit forfour (4) StimulationChannels and UserInterface iscombined into samecasing, connected tothe electrodes with6-pole cables.on thestimulatedmuscles.The varioustypes of musclework that the E-Fit EF-1280 canimpose on thestimulatedmuscles are ableto improve orfacilitate muscleperformance.The E-Fit EF-1280 maytherefore beconsidered atechnique ofmuscle training.The EF-1280unit is connectedto the electrodesvia a cableelectrodeharness which isconnected to theEMS devicewith a physicalconnection. Theconnection tothe EMS device1s via a plastic12pinwaterproof ip68Connector andthe connectionto the electrodesis via SNAPconnectorsdirectly onto theouter vest andK083140 -SimilarK133225 -SimilarLED backlight.The rotaryencoder allowsfor a quick setupand ease of useDifferentSee section1.10Differencesbelow forjustificationofdifferences
PowerSource(s)Li-Po Battery3.8V, 7.79WhRechargeable Ni-MhBattery 4.6V (4 cellsleg straps.Lead AcidBatteryK083140 -DifferentPer ChannelControlYes. Using Windows 10control applicationYes, Usingintegrated buttons.Yes. Usingrotary encoderknobs for eachchannel.K083140 -SimilarK133225 -Similar
(2050mAh)AA=R6)K133225 -ElectrodePlacementIntegrated into wearablebody suit and positionedover correspondingmuscle group positions.Cannot bemodified/altered.Not defined.Placement ofelectrodes isdictated by theoperator.Placed into outerlayer,appropriatelypositioned overcorrespondingmuscle grouppositions.Cannot bemodified/altered.K083140 -DifferentK133225 -Similar
IEC 62133: 2012 (2ndEdition)12V, 3400mAHDifferentElectrodeLeads21 CFR 898 compliant.21 CFR 898compliant.21 CFR 898compliant.K083140 -SimilarK133225 -Similar
ChargingSystemAC/DC wall plug in,distributed directly to thedevice. 18.0[v], 1.33[A]AC/DC 9[v] 0.4[A]Distributed directly tothe deviceAC/DC wallplug in,distributeddirectly to thedevice.K083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectiveness of thedeviceElectrodeInterface4mm Standard SNAPConnector.4mm StandardSNAP Connector.4mm StandardSNAPConnector.K083140 -SimilarK133225 -Similar
WaveformBipolar SquareBipolar SquareBipolar SquareK083140 -SimilarK133225 -SimilarElectrodesOnly 2 per channel; Max20.2 per channel; Max8.2 per channel;Max 24.K083140 -SimilarK133225 -Similar
Channels10412K083140 -DifferentK133225 -SimilarTransthoracicstimulationYesNoYesK083140 -DifferentK133225 -Similarelectrodeplacementand safetymitigationsas K133225
OperationModes395+5K083140 -SimilarK133225 -Different
ChargingIsolationYesYesYesK083140 -SimilarK133225 -Similar
RechargeableIntegratedBatteryYesYesYesK083140 -SimilarK133225 -Similar
Display /ControlYes; (LCD Display onMicrosoft Surface Pro 3Yes, Integrated(LCD)LCD 2x40character LCDK083140 -Different

{8}------------------------------------------------

{9}------------------------------------------------

{10}------------------------------------------------

Communicationwith ControlInterfaceBluetooth Smart (BT LE4.0).DifferentK133225 -DifferentSee section1.10Differencesbelow forjustificationofdifferences
Mobile / FormFactorYes (tablet, handhelddevice and wearablesuit).Yes (pocket devicewith travel case)Portable withdifficulty, nomobile device,its intended userequires thequalified andtrained operator.K083140 -SimilarK133225 -Similar
ChannelControlInterfaceTouch User Interfaceprovided by KatalystApplication on SurfacePro 3 PCPhysical Buttonsand Display on unit.Using rotaryencoder knobsfor each channeland masterrotary encoderfor all channels.K083140 -DifferentK133225 -DifferentSee section1.10Differencesbelow forjustificationofdifferences
Instant ShutoffPhysical ButtonPhysical ButtonPhysical ButtonK083140 -SimilarK133225 -Similar
MicroprocessorControlled?YesYesYesK083140 -SimilarK133225 -Similar
Automaticoverload trip?YesYesYesK083140 -SimilarK133225 -Similar
Automatic No-Load Trip?YesYesYesK083140 -SimilarK133225 -Similar
AutomaticShutoff?On/Off SwitchOn/Off SwitchOn/Off SwitchK083140 -SimilarK133225 -Similar
PatientOverrideControl?YesYesYesK083140 -SimilarK133225 -Similar
InterfaceIndicatorsOn/Off - Yes (onImpulse Pack via LEDand in application)Low Battery - Yes (onImpulse Pack)Voltage/Current Level -Yes (in application).Charging - yes onImpulse Pack.Duration of training- yes(in application)On/Off - yesLow Battery - yesVoltage/CurrentLevel - yesCharging - yesDuration of trainingtraining- yes.On/Off - yesLow Battery -yesVoltage/CurrentLevel - yesCharging - yesDuration oftrainingtraining- yes.K083140 -SimilarK133225 -Similar
Duration inminutes40 (shown on display)5530 minutesK083140 -SimilarK133225 -Similar

{11}------------------------------------------------

Table 10: Device Characteristic Comparisons

1.9 Output Specification - Comparison with Predicate Devices

CharacteristicNew Device(Katalyst Mark 1Muscle StimulationSystem)Primary Predicate:Compex Sport Plus(K083140)SecondaryPredicate: E-Fit EF-1280(K133225)Similar/Different
WaveformSymmetricalBiphasicSymmetricalBiphasicSymmetricalBiphasicK083140 -SimilarK133225 -
Similar
ShapeRectangularRectangularRectangularK083140 -SimilarK133225 -Similar
Maximum OutputVoltage (+/- 10%)60 V @ 500 Ω96 V @ 2 kΩ114.2 V @ 10 kΩ60 V @ 500 Ω165 V @ 2 kΩ165 V @ 10 kΩ36 V @ 500 ΩK083140 -SimilarK133225 -Different
Maximum OutputCurrent (+/- 10%)120 mA @ 500 Ω48 mA @ 2 kΩ11 mA @ 10 kΩ120 mA @ 500 Ω82 mA @ 2 kΩ16 mA @ 10 kΩ72 mA @ 500 ΩK083140 -SimilarK133225 -Different
Positive Pulse Width75µs or175µs200 µs to 400 µs100µs to500µsK083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
Negative Pulse Width75µs or175µs200 µs to 400 µs100µs to500µsK083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
Frequency85Hz or 100Hz1 to 120Hz5 to 120HzK083140 -SimilarK133225 -Different
For interferentialmodes only:NoNoNoK083140 -SimilarK133225 -Similar
For multiphasicwaveforms only:YesYesYesSimilarK133225 -Similar
- Symmetricalphases?YesYesYesK083140 -SimilarK133225 -Similar
- Phase Duration(include units)(state range, ifapplicable)(both phases, ifasymmetrical)75µs Symmetrical or175uSecSymmetrical70-200µsSymmetrical100 - 500µsSymmetricalK083140 -SimilarK133225 -Different
Net Charge[µC/pulse]$0.5 [\mu C] @ 500\Omega$Excitation pulse fullycompensated$0 [\mu C] @ 500\Omega$Excitation pulsefully compensated$0 [\mu C] @ 500\Omega$Excitationpulse fullycompensatedK083140 -SimilarK133225 -Similar
Maximum PhaseCharge [µC]$21\mu C @ 500 \Omega$$48\mu C @ 500\Omega$$36\mu C @ 500 \Omega$K083140 -SimilarK133225 -Similar
Maximum Current(RMS) Density[mA/cm2]$2.4mA/cm^2 @500\Omega$$1.49mA/cm^2 @ 500\Omega$$0.85mA/cm^2 @ 500\Omega$K083140 -DifferentK133225 -DifferentSee section1.10Differencesbelow forjustificationofdifferences
Maximum PowerDensity [mW/cm2]$5.04mW/cm^2 @ 500 \Omega$$27.6mW/cm^2 @500\Omega$$6.3mW/cm^2 @ 500 \Omega$K083140 -SimilarK133225 -Similar
Burst Mode(i.e., pulse trains)N/AUnknownUnknownK083140 -UnknownK133225 -
c. Burst duration(seconds)
d. Duty Cycle [Line(b) x Line (c)]
ON Time (seconds)1 or 4, 1 secondintervals(software adjustablemodes)Not Adjustable0.1 to 60seconds, 0.1secondintervals(adjustablewithin range)K083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
OFF Time (seconds)1 or 4, 1 secondintervals(software adjustablemodes)Not Adjustable0.1 to 60seconds, 0.1secondintervals(adjustablewithin range)K083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
Treatment TrainingTime1-40 minutes, 1-minute intervals(software adjustablewithin range)Not Adjustable1-30 minutes,1-minuteintervals(adjustablewithin range)K083140 -DifferentK133225 -SimilarDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
Ramp up time perimpulse0 seconds or 300ms(software adjustablewithin range)Not Adjustable0 ms - 5000ms, 100msintervals(adjustablewithin range)K083140 -DifferentK133225 -DifferentDifferencedoes notadverselyaffect thesafety andeffectivenessof the device
does notadverselyaffect thesafety andeffectivenessof the device

{12}------------------------------------------------

{13}------------------------------------------------

{14}------------------------------------------------

{15}------------------------------------------------

Table 11: Output Specification Comparisons

1.10 Differences

Fundamentally, when we compare the core design, output specifications, operating behavior, intended use and general modes of operation we can conclude there is little difference between the Compex Sport Plus, EF-1280, and the Katalyst Mark 1 Muscle Stimulator.

The following table outlines the essential differences with justifications for how the differences do not adversely impact the safety and effectiveness of the subject device.

DifferenceAdditional DetailsJustification for howthe difference doesnot adversely impactsafety andeffectiveness
Katalyst Mark 1's use ofwireless communicationbetween the controllerdevice and the impulsegenerator.In order to better utilizemodern interfaces alongsidewith strong and robustplatforms. Katalyst utilizes aBluetooth Smart connectionbetween its interface controllerand the impulse pack.System validationtesting scenarioscovering mitigation ofwireless risks inaccordance withFDA's “RadioFrequency WirelessTechnology in MedicalDevices - Guidance forIndustry and Food andDrug AdministrationStaff” were added toour full system testingprotocol to ensure safeand effective useIn addition, this issimilar to thePowerDot Pd-01Muscle Stimulator(with PowerDotMobile Application)(K150078)
Using a tablet / touchinterface to controlchannel impulseintensities.The touch application is usedto control the impulseintensities wirelessly viaBluetooth.Impulse Packfirmware and KatalystApplication softwaredocumentation,consistent with aModerate level ofconcern, is providedwith this 510(k).System ValidationTesting proves that allsoftware requirementspecifications weremet and all softwarehazards were mitigatedto Accepted risk levelIn addition, this issimilar to thePowerDot Pd-01Muscle Stimulator(with PowerDotMobile Application)(K150078)
The Katalyst Mark 1 has acurrent density (RMS)greater than 2mA/cm²As outlined in IEC 60601-2-10additional warnings andguidance are included in theOperator's Guide to properlyadvice operators on properprocedures to increase tointensities.The Katalyst Mark 1has been tested andconformed to the IEC60601-2-10:2012"Medical electricalequipment - Part 2-10:Particularrequirements for thebasic safety andessential performanceof nerve and musclestimulators." Edition2.0 standard.Furthermore, thesubject device hascomplied with therecommendations setforth in FDA's"Guidance Documentfor Powered MuscleStimulator 510(k)s"
issued on June 9, 1999In addition, CompexSport (K011880) has acurrent density of3.84mA/cm² whichincludes similarwarnings andguidance.

{16}------------------------------------------------

{17}------------------------------------------------

1.11 Non-Clinical Tests

The following non-clinical testing was provided in this 510(k):

Biocompatibility Testing

Skin contacting electrodes pads have been tested to ISO 10993-10:2009 and ISO 10993-5:2009 standard under GLP.

Software Verification and Validation

Impulse Pack firmware and Katalyst Application software documentation, consistent with a Moderate level of concern, is provided with this 510(k).

System Validation Testing proves that all software requirement specifications were met and all software hazards were mitigated to Accepted risk level.

Electrical Safety and Electromagnetic Compatibility Testing

The Katalyst Suit and the Impulse Pack have been designed to comply and tested for compatibility with the applicable clauses of the following FDA-recognized standards:

  • . IEC/EN 60601-1:2005 "Medical Electrical Equipment - Part 1: General Requirements for Safety" Edition 3.1
  • . IEC 60601-2-10:2012 "Medical electrical equipment - Part 2-10: Particular requirements for the basic safety and essential performance of nerve and muscle stimulators." Edition 2.0
  • . IEC/EN 60601-1-2:2014 "Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic Disturbances. Edition 4.0

Battery Testing

Lithium-Polymer battery, used in Impulse Pack was tested by battery manufacturer for compliance with IEC 62133 Edition 2.0.

{18}------------------------------------------------

Engineering Bench Testing

In addition to the full system validation testing, the 510(k) also included testing in accordance with the recommendations of FDA's "Guidance Document for Powered Muscle Stimulator 510(k)s" issued on June 9, 1999. Oscilloscope tracings were obtained of the device output waveforms under maximum supported voltage and pulse widths under loads of 500 Ω. 2 kΩ and 10 kΩ. Also, several system validation testing scenarios covering mitigation of wireless risks in accordance with FDA's "Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and Food and Drug Administration Staff" were added to our full system testing protocol.

Conclusion 1.12

Test results demonstrate the Katalyst Mark 1 Muscle Stimulation System is substantially equivalent to the predicate devices.

§ 890.5850 Powered muscle stimulator.

(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).